Status:

COMPLETED

INSPIRE Continuation Post-Approval Study

Lead Sponsor:

TransMedics

Conditions:

Bronchiolitis Obliterans

Eligibility:

All Genders

Brief Summary

To evaluate long-term BOS-free survival outcomes of the OCS™ Lung INSPIRE Trial patients.

Eligibility Criteria

Inclusion

  • Participant in TransMedics OCS Lung System INSPIRE trial

Exclusion

  • None

Key Trial Info

Start Date :

June 30 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 12 2021

Estimated Enrollment :

220 Patients enrolled

Trial Details

Trial ID

NCT03868904

Start Date

June 30 2019

End Date

October 12 2021

Last Update

April 7 2022

Active Locations (17)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (17 locations)

1

St. Joseph's Hospital and Medical Center

Phoenix, Arizona, United States, 85013

2

UCLA Medical Center

Los Angeles, California, United States, 90095

3

University of California at San Francisco

San Francisco, California, United States, 94143

4

Indiana University

Indianapolis, Indiana, United States, 46202

INSPIRE Continuation Post-Approval Study | DecenTrialz